Published in Trends Endocrinol Metab on September 04, 2009
The G-protein-coupled estrogen receptor GPER in health and disease. Nat Rev Endocrinol (2011) 2.33
Bradycardic effects mediated by activation of G protein-coupled estrogen receptor in rat nucleus ambiguus. Exp Physiol (2012) 1.51
Obesity, insulin resistance and diabetes: sex differences and role of oestrogen receptors. Acta Physiol (Oxf) (2011) 1.48
Activation of GPR30 attenuates diastolic dysfunction and left ventricle remodelling in oophorectomized mRen2.Lewis rats. Cardiovasc Res (2012) 1.01
Post-synaptic density-95 (PSD-95) binding capacity of G-protein-coupled receptor 30 (GPR30), an estrogen receptor that can be identified in hippocampal dendritic spines. J Biol Chem (2013) 1.01
Membrane estrogen signaling enhances tumorigenesis and metastatic potential of breast cancer cells via estrogen receptor-α36 (ERα36). J Biol Chem (2012) 0.99
The G protein-coupled receptor 30 is up-regulated by hypoxia-inducible factor-1alpha (HIF-1alpha) in breast cancer cells and cardiomyocytes. J Biol Chem (2011) 0.98
Equol-stimulated mitochondrial reactive oxygen species activate endothelial nitric oxide synthase and redox signaling in endothelial cells: roles for F-actin and GPR30. Hypertension (2011) 0.97
Identification of the estrogen receptor GPER in neoplastic and non-neoplastic human testes. Reprod Biol Endocrinol (2011) 0.95
Rapid control of male typical behaviors by brain-derived estrogens. Front Neuroendocrinol (2012) 0.95
GPR30, but not estrogen receptor-alpha, is crucial in the treatment of experimental autoimmune encephalomyelitis by oral ethinyl estradiol. BMC Immunol (2010) 0.95
Estrogen Effects on Cognitive and Synaptic Health Over the Lifecourse. Physiol Rev (2015) 0.95
G-protein-coupled receptor 30 interacts with receptor activity-modifying protein 3 and confers sex-dependent cardioprotection. J Mol Endocrinol (2013) 0.92
G protein-coupled oestrogen receptor 1 (GPER1)/GPR30: a new player in cardiovascular and metabolic oestrogenic signalling. Br J Pharmacol (2011) 0.92
PTEN and p53 cross-regulation induced by soy isoflavone genistein promotes mammary epithelial cell cycle arrest and lobuloalveolar differentiation. Carcinogenesis (2010) 0.91
Interplay of estrogen receptors and FOXA factors in the liver cancer. Mol Cell Endocrinol (2015) 0.90
G protein-coupled estrogen receptor 1-mediated effects in the rat myometrium. Am J Physiol Cell Physiol (2011) 0.90
17β-estradiol signaling and regulation of Sertoli cell function. Spermatogenesis (2011) 0.89
Estradiol and tamoxifen induce cell migration through GPR30 and activation of focal adhesion kinase (FAK) in endometrial cancers with low or without nuclear estrogen receptor α (ERα). PLoS One (2013) 0.85
The many faces of estrogen signaling. Biochem Med (Zagreb) (2014) 0.84
Emerging roles of GPER in diabetes and atherosclerosis. Trends Endocrinol Metab (2015) 0.84
Influence of charge on cell permeability and tumor imaging of GPR30-targeted 111in-labeled nonsteroidal imaging agents. ACS Chem Biol (2010) 0.81
Estradiol meets notch signaling in developing neurons. Front Endocrinol (Lausanne) (2011) 0.79
G protein-coupled estrogen receptor in energy homeostasis and obesity pathogenesis. Prog Mol Biol Transl Sci (2013) 0.79
Activation of GPR30 inhibits cardiac fibroblast proliferation. Mol Cell Biochem (2015) 0.79
17β-Estradiol induces vasorelaxation in a G-protein-coupled receptor 30-independent manner. Naunyn Schmiedebergs Arch Pharmacol (2012) 0.79
GPR30 regulates diet-induced adiposity in female mice and adipogenesis in vitro. Sci Rep (2016) 0.79
Identification of G protein-coupled estrogen receptor in human and pig spermatozoa. J Anat (2014) 0.78
GPER-novel membrane oestrogen receptor. Clin Sci (Lond) (2016) 0.78
Estradiol Binds to Insulin and Insulin Receptor Decreasing Insulin Binding in vitro. Front Endocrinol (Lausanne) (2014) 0.77
GPER1 (GPR30) knockout mice display reduced anxiety and altered stress response in a sex and paradigm dependent manner. Horm Behav (2014) 0.77
G protein-coupled estrogen receptor-mediated effects on cytosolic calcium and nanomechanics in brain microvascular endothelial cells. J Neurochem (2015) 0.77
GPR30 FORMS AN INTEGRAL PART OF E2-PROTECTIVE PATHWAY IN EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS. Immunol Endocr Metab Agents Med Chem (2011) 0.77
GPER-targeted, 99mTc-labeled, nonsteroidal ligands demonstrate selective tumor imaging and in vivo estrogen binding. Mol Cancer Res (2014) 0.76
The complex nature of oestrogen signalling in breast cancer: enemy or ally? Biosci Rep (2016) 0.76
Hetereogeneity of dose and time effects of estrogen on neuron-specific neuronal protein and phosphorylated cyclic AMP response element-binding protein in the hippocampus of ovariectomized rats. J Neurosci Res (2011) 0.75
GPER/GPR30, a membrane estrogen receptor, is expressed in the brain and retina of a social fish (Carassius auratus) and colocalizes with isotocin. J Comp Neurol (2016) 0.75
Cytoplasm estrogen receptor β5 as an improved prognostic factor in thymoma and thymic carcinoma progression. Oncol Lett (2015) 0.75
The Unique Dopamine/Ecdysteroid Receptor Modulates Ethanol-Induced Sedation in Drosophila. J Neurosci (2016) 0.75
G-protein-coupled estrogen receptor-30 gene polymorphisms are associated with uterine leiomyoma risk. Bosn J Basic Med Sci (2016) 0.75
Non-genomic actions of 17-β estradiol restore respiratory neuroplasticity in young ovariectomized female rats. J Neurosci (2017) 0.75
Deletion of the G protein-coupled receptor 30 impairs glucose tolerance, reduces bone growth, increases blood pressure, and eliminates estradiol-stimulated insulin release in female mice. Endocrinology (2008) 2.09
Lysophosphatidic acid binds to and activates GPR92, a G protein-coupled receptor highly expressed in gastrointestinal lymphocytes. J Pharmacol Exp Ther (2006) 1.78
PI 3-kinase regulation of dopamine uptake. J Neurochem (2002) 1.64
G protein-coupled estrogen receptor 1/G protein-coupled receptor 30 localizes in the plasma membrane and traffics intracellularly on cytokeratin intermediate filaments. Mol Pharmacol (2010) 1.14
Bradykinin receptor subtype 1 expression and function in prostate cancer. Cancer Res (2003) 1.07
Kinins promote B2 receptor endocytosis and delay constitutive B1 receptor endocytosis. Mol Pharmacol (2006) 1.03
The GPER1 agonist G-1 attenuates endothelial cell proliferation by inhibiting DNA synthesis and accumulating cells in the S and G2 phases of the cell cycle. J Vasc Res (2011) 1.02
Requirement for direct cross-talk between B1 and B2 kinin receptors for the proliferation of androgen-insensitive prostate cancer PC3 cells. Biochem J (2003) 0.98
Activation of TAFI on the surface of Streptococcus pyogenes evokes inflammatory reactions by modulating the kallikrein/kinin system. J Innate Immun (2008) 0.93
G-protein-coupled receptor 30 interacts with receptor activity-modifying protein 3 and confers sex-dependent cardioprotection. J Mol Endocrinol (2013) 0.92
Human B1 and B2 bradykinin receptors and their agonists target caveolae-related lipid rafts to different degrees in HEK293 cells. Biochemistry (2002) 0.92
G protein-coupled oestrogen receptor 1 (GPER1)/GPR30: a new player in cardiovascular and metabolic oestrogenic signalling. Br J Pharmacol (2011) 0.92
Neutrophil-derived proteinase 3 induces kallikrein-independent release of a novel vasoactive kinin. J Immunol (2009) 0.91
Kinin receptor expression during Staphylococcus aureus infection. Blood (2006) 0.89
Jak2 and Ca2+/calmodulin are key intermediates for bradykinin B2 receptor-mediated activation of Na+/H+ exchange in KNRK and CHO cells. Assay Drug Dev Technol (2003) 0.83
The G protein-coupled oestrogen receptor 1 agonist G-1 disrupts endothelial cell microtubule structure in a receptor-independent manner. Mol Cell Biochem (2012) 0.80
Spontaneous formation of a proteolytic B1 and B2 bradykinin receptor complex with enhanced signaling capacity. J Biol Chem (2004) 0.80
Calcium-sensing receptor-mediated ERK1/2 activation requires Galphai2 coupling and dynamin-independent receptor internalization. J Biol Chem (2003) 0.80
Lack of G protein-coupled estrogen receptor (GPER) in the plasma membrane is associated with excellent long-term prognosis in breast cancer. Breast Cancer Res Treat (2014) 0.80
The G protein-coupled estrogen receptor 1 (GPER1/GPR30) agonist G-1 regulates vascular smooth muscle cell Ca²⁺ handling. J Vasc Res (2013) 0.79
Kinin B2 receptor-mediated bradykinin internalization and metalloendopeptidase EP24.15-dependent intracellular bradykinin degradation. J Pharmacol Exp Ther (2008) 0.78
Kinin B1 receptor homo-oligomerization is required for receptor trafficking to the cell surface. Int Immunopharmacol (2012) 0.78
Kinin-stimulated B1 receptor signaling depends on receptor endocytosis whereas B2 receptor signaling does not. Neurochem Res (2013) 0.77
B1 bradykinin receptor homo-oligomers in receptor cell surface expression and signaling: effects of receptor fragments. Mol Pharmacol (2004) 0.77
Infection-induced kinin B1 receptors in human pulmonary fibroblasts: role of intact pathogens and p38 mitogen-activated protein kinase-dependent signaling. J Pharmacol Exp Ther (2005) 0.77
G protein-coupled estrogen receptor is apoptotic and correlates with increased distant disease-free survival of estrogen receptor-positive breast cancer patients. Clin Cancer Res (2013) 0.76
Acute hypothalamo-pituitary-adrenal axis response to LPS-induced endotoxemia: expression pattern of kinin type B1 and B2 receptors. Biol Chem (2016) 0.75
Exploring the future of local vascular and inflammatory mediators. Biol Chem (2006) 0.75